Quantum Dots
In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.
Insights from our team
Vector Laboratories' blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
Click Chemistry Crosslinking with dPEG®
In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.
Maleimide Crosslinker Selection Guide
In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.
Vector Laboratories Launches Glysite™ Explorer in situ PLA Glycan Detection Kit to Advance Functional Proteomics Research
NEWARK, Calif.July 15, 2025 The new kit combines Vector’s validated lectins with Navinci’s in situ PLA technology to gain insights beyond protein expression. Vector Laboratories, a leader in innovative proteomic and glycomic research solutions, and... Read more
A Career of Antibody Drug Conjugates
From different modalities to overcoming aggregation; we find out what advances are affecting the development of ADCs…
Vector Laboratories and Spatomics Present Novel Method for Multiplexed Spatial Profiling of Glycans and Proteins at AACR
NEWARK, Calif.April 28, 2025 Leader in manufacturing reagents and critical components for biomedical research partners with spatial biology solutions company to support simultaneous detection of 10+ markers in a single tissue sample using off-the-shelf antibodies... Read more
Vector Laboratories Announces the Appointment of Ashley Scholz as Vice President of Marketing
NEWARK, Calif.February 24, 2025 Accomplished marketing leader to drive strategic growth and customer-first initiatives. Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and... Read more
Vector Laboratories Announces Partnership With British Biotech Innovator Etcembly
NEWARK, Calif.February 20, 2025 Leader in manufacturing reagents and critical components for biomedical research to leverage Etcembly’s AI platform to optimize antibody engineering. Vector Laboratories, a manufacturing partner of reagents and critical components for the... Read more
The art of the antibody curator
Thinking on linkers for antibody-drug conjugates
In the chemical world, the tiny hyphen in antibody-drug conjugates—or ADCs, as they’re commonly known—does a lot more work than the perfunctory punctuation suggests.
